Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (111-120 of 320) with videos related to

Pageof 32
Sort By:
Plos One|December 31, 2013
Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinomaKatelin N Townsend, Jaeline E Spowart, Hassan Huwait, et al.
The American Journal of Pathology|April 24, 2018
High Frequency of Ovarian Cyst Development in Vhl<sup>2B/+</sup>;Snf5<sup>+/-</sup> MiceYasumichi Kuwahara, Leslie M Kennedy, Anthony N Karnezis, et al.
The Journal of Pathology|May 19, 2011
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomasKimberly C Wiegand, Anna F Lee, Osama M Al-Agha, et al.
Molecular Cancer Research : MCR|February 11, 2017
Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian CarcinomaLindsay DeVorkin, Matthew Hattersley, Paul Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenograftsUrsula Kortmann, Jessica N McAlpine, Hui Xue, et al.
Gynecologic Oncology|October 17, 2017
LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancersZhouchunyang Xia, Dawn R Cochrane, Michael S Anglesio, et al.
Genes, Chromosomes & Cancer|March 5, 2008
Amplification of 11q13 in ovarian carcinomaLindsay A Brown, Steve E Kalloger, Melinda A Miller, et al.
The Journal of Pathology|July 6, 2017
Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?Dawn R Cochrane, Basile Tessier-Cloutier, Katherine M Lawrence, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinomaNikita A Makretsov, David G Huntsman, Torsten O Nielsen, et al.
Pageof 32

Showing results (111-120 of 320) with videos related to

Sort By:
Pageof 32
Plos One|December 31, 2013
Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinomaKatelin N Townsend, Jaeline E Spowart, Hassan Huwait, et al.
The American Journal of Pathology|April 24, 2018
High Frequency of Ovarian Cyst Development in Vhl<sup>2B/+</sup>;Snf5<sup>+/-</sup> MiceYasumichi Kuwahara, Leslie M Kennedy, Anthony N Karnezis, et al.
The Journal of Pathology|May 19, 2011
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomasKimberly C Wiegand, Anna F Lee, Osama M Al-Agha, et al.
Molecular Cancer Research : MCR|February 11, 2017
Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian CarcinomaLindsay DeVorkin, Matthew Hattersley, Paul Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenograftsUrsula Kortmann, Jessica N McAlpine, Hui Xue, et al.
Gynecologic Oncology|October 17, 2017
LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancersZhouchunyang Xia, Dawn R Cochrane, Michael S Anglesio, et al.
Genes, Chromosomes & Cancer|March 5, 2008
Amplification of 11q13 in ovarian carcinomaLindsay A Brown, Steve E Kalloger, Melinda A Miller, et al.
The Journal of Pathology|July 6, 2017
Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?Dawn R Cochrane, Basile Tessier-Cloutier, Katherine M Lawrence, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinomaNikita A Makretsov, David G Huntsman, Torsten O Nielsen, et al.
Pageof 32